Skip to content

Clinical trials

Completed Alzheimer Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Canada Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20033
20045
20053
20065
20078
20087
200914
20105
20114
201212
20138
201411
20157
201611
20178
20187
20195
20203
20219
202211
20234
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed158

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company8
Pfizer7
GlaxoSmithKline6
Sunnybrook Health Sciences Centre6
Université de Sherbrooke5
Boehringer Ingelheim4
H. Lundbeck A/S4
Hoffmann-La Roche4
McMaster University4
Queen's University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease158
Dementia38
Cognitive Dysfunction24
Psychomotor Agitation8
Memory Disorders6
Pick Disease of the Brain6
Neurodegenerative Diseases5
Plaque, Amyloid5
Amyloid Neuropathies, Familial4
Brain Diseases4

Trials

Showing 1 to 25 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.